quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:01:52·1204d
NEWSRelease
AMTD IDEA Group logo
Argo Blockchain plc logo
Arbor Rapha Capital Bioholdings Corp. I logo
+16

Why Geron Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket

AMTD· AMTD IDEA GroupARBK· Argo Blockchain plcARCK· Arbor Rapha Capital Bioholdings Corp. ICRKN· Crown Electrokinetics Corp.DRMA· Dermata Therapeutics Inc.GERN· Geron Corporation
FinanceIndustrialsTechnology
Original source

Companies

  • AMTD
    AMTD IDEA Group
    Finance
  • ARBK
    Argo Blockchain plc
    Finance
  • ARCK
    Arbor Rapha Capital Bioholdings Corp. I
    Industrials
  • CRKN
    Crown Electrokinetics Corp.
    Technology
  • DRMA
    Dermata Therapeutics Inc.
    Health Care
  • GERN
    Geron Corporation
    Health Care
  • HGEN
    Humanigen Inc.
    Health Care
  • INM
    InMed Pharmaceuticals Inc.
    Health Care
  • JAN
    Janus Living Inc.
    Real Estate
  • JSPR
    Jasper Therapeutics Inc.
    Health Care
  • KPRX
    Kiora Pharmaceuticals Inc.
    Health Care
  • NUWE
    Nuwellis Inc.
    Health Care
  • OBLG
    Oblong Inc.
    Technology
  • PBTS
    Powerbridge Technologies Co. Ltd.
    Technology
  • PSTV
    PLUS THERAPEUTICS Inc.
    Health Care
  • TCBP
    TC BioPharm (Holdings) plc
    Health Care
  • TYDE
    Cryptyde Inc.
  • VVOS
    Vivos Therapeutics Inc.
    Health Care
  • VYNT
    Vyant Bio Inc.
    Health Care

Recent analyst ratings

  • Apr 14JANUpdateScotiabank$28.00
  • Apr 14JANUpdateKeyBanc Capital Markets$28.00
  • Apr 14JANUpdateBarclays$26.00
  • Apr 14JANUpdateMorgan Stanley$28.00
  • Apr 14JANUpdateRBC Capital Mkts$27.00
  • Apr 14JANUpdateAnalyst$26.00

Related

  • PR23h
    Nuwellis to Participate in the AATS 106th Annual Meeting and ERAS Cardiac Spring Retreat
  • PR1d
    Plus Therapeutics Initiates Manufacturing Activities with SpectronRx Under a Master Services Agreement to Support GMP Pivotal Trial Readiness for REYOBIQ™
  • INSIDER1d
    SEC Form 4 filed by Daniels Eric Joseph
  • PR1d
    Plus Therapeutics Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
  • SEC1d
    Vivos Therapeutics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • SEC1d
    Amendment: SEC Form SCHEDULE 13G/A filed by Dermata Therapeutics Inc.
  • PR2d
    Geron Plans to Announce First Quarter 2026 Financial Results on May 6, 2026
  • INSIDER2d
    SEC Form 3 filed by new insider Daniels Eric Joseph
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022